—

Globus Medical (GMED) — Technical state

As of 2026-11-09 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 60 out of 100 (momentum 37 · quality 65 · valuation 53), as of 2026-11-11.
  • Signal: Up 7.5% at the close — one of the day's strongest moves. (as of 2026-11-09)
  • Trend: Globus Medical trades 0.9% below its 50-day and 8.1% below its 200-day moving average. (as of 2026-11-09)
  • Index seat: HALO Growth 100

Globus Medical makes implants and instruments for spine, orthopaedic trauma and hip-and-knee surgery, treating musculoskeletal disorders. It also builds the ExcelsiusGPS robotic guidance platform and related navigation and neuromonitoring tools used during procedures.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the GMED overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Up 7.5% at the close

one of the day's strongest moves.

The moving-average stack

FAQ · from the current data · as of 2026-11-09

Quick answers

What is the current Closelooknet signal on GMED?

Up 7.5% at the close — one of the day's strongest moves. As of 2026-11-09; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is GMED above its 50-day and 200-day moving averages?

As of 2026-11-09, Globus Medical trades -0.9% below its 50-day and -8.1% below its 200-day average, with the 20-day -3.6% away.

How far is GMED from its 52-week high?

24.7% below the 52-week high and 35.2% above the 52-week low, as of 2026-11-09.

Related in the Closelooknet universe

same Closelooknet index seat first, then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.